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Abstract: QueF enzymes catalyze the nicotinamide adenine dinucleotide phosphate (NADPH)-dependent
reduction of the nitrile group of 7-cyano-7-deazaguanine (preQ0) to 7-aminomethyl-7-deazaguanine
(preQ1) in the biosynthetic pathway to the tRNA modified nucleoside queuosine. The QueF-catalyzed
reaction includes formation of a covalent thioimide intermediate with a conserved active site
cysteine that is prone to oxidation in vivo. Here, we report the crystal structure of a mutant of
Bacillus subtilis QueF, which reveals an unanticipated intramolecular disulfide formed between the
catalytic Cys55 and a conserved Cys99 located near the active site. This structure is more symmetric
than the substrate-bound structure and exhibits major rearrangement of the loops responsible for
substrate binding. Mutation of Cys99 to Ala/Ser does not compromise enzyme activity, indicating
that the disulfide does not play a catalytic role. Peroxide-induced inactivation of the wild-type
enzyme is reversible with thioredoxin, while such inactivation of the Cys99Ala/Ser mutants is
irreversible, consistent with protection of Cys55 from irreversible oxidation by disulfide formation
with Cys99. Conservation of the cysteine pair, and the reported in vivo interaction of QueF with the
thioredoxin-like hydroperoxide reductase AhpC in Escherichia coli suggest that regulation by the
thioredoxin disulfide-thiol exchange system may constitute a general mechanism for protection of
QueF from oxidative stress in vivo.
Keywords: tRNA modification; oxidoreductase; tunneling fold
1. Introduction
QueF is the nicotinamide adenine dinucleotide phosphate (NADPH)-dependent nitrile reductase
that functions in the biosynthetic pathway of the tRNA-modified nucleoside queuosine (Q, [1]),
a 7-deazaguanosine nucleoside found at the wobble position of bacterial and eukaryotic tRNAs
possessing the GUN anticodon (those encoding for Tyr, His, Asp and Asn) [2]. QueF catalyzes
the NADPH-dependent 4-electron reduction of the nitrile group of the pathway intermediate
7-cyano-7-deazaguanine (preQ0) to 7-aminomethyl-7-deazaguanine (preQ1), the last intermediate
in the tRNA-independent portion of the pathway [1] (Figure 1). PreQ1 is subsequently inserted into
the tRNA by the enzyme tRNA-guanine transglycosylase [3], and the remainder of the pathway occurs
on the tRNA [4,5]. Although Q is essential for translational fidelity and efficiency in both Bacteria
Biomolecules 2017, 7, 30; doi:10.3390/biom7010030 www.mdpi.com/journal/biomolecules
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and Eukarya [6–9], de novo Q biosynthesis, hence the entire tRNA-independent portion of the Q
pathway, including the QueF step, occurs only in Bacteria [4,10]. The QueF catalyzed reaction is the
only example of biological nitrile reduction known to date.
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QueF enzymes from Bacillus subtilis [1,11], Vibrio cholera [12], Geobacillus kaustophilus [13],
and Escherichia coli [14,15] have been biochemically characterized, and a number of mechanistic
investigations have been reported [11,16–18]. The reaction begins with the binding of preQ0 and its
reaction with the thiol of an active site cysteine (Cys55 in the B. subtilis enzyme) [11,16] to form a
covalent thioimide intermediate (Figure 2, I). This intermediate is very stable, with a rate constant for
decomposition of ~5 × 10−6 s−1 [16]. NADPH then binds and delivers the first hydride equivalent
to generate a covalent thiohemiaminal (Figure 2, II) intermediate. After dissociation of NADP+ and
binding of the second equivalent of NADPH, II breaks down to form an imine (Figure 2, III), which is
then reduced to preQ1.
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QueF belongs to the tunnelling fold (T-fold) structural superfamily of purine/pterin binding
proteins. T-fold proteins share a small domain (T-fold domain) that consists of a f ur-stranded
antiparallel β sheet and two α helices bet een the 2nd and 3rd strands (ββαββ) laying on one face
of the β sheet [19]. QueF enzymes fall i to two subfamilies: the unimod lar subfamily, exemplified
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by B. subtilis QueF, is comprised of proteins that are constructed from subunits possessing a single
T-fold domain, whereas the bimodular subfamily—e.g., V. cholerae and E. coli QueF—is comprised
of proteins that are constructed from subunits possessing two weakly homologous tandem T-fold
domains [1]. B. subtilis QueF, a ~160 amino acid protein with a single T-fold domain, is a homodecamer
of two head-to-head facing pentamers, each composed of a cyclic arrangement of monomeric T-fold
subunits, forming a tunnel in the center (Figure 3A) [16]. The homodecamer contains 10 active sites at
the intersubunit interfaces. V. cholera QueF, a ~280 amino acid polypeptide with two tandem T-fold
domains, exists as a homodimer with two active sites located at the interfaces between the two T-fold
domains within the monomeric subunits (Figure 3B) [12]. This quaternary structure does not exhibit
a central tunnel, hence V. cholerae QueF does not conform to the canonical T-fold assembly. Both
QueF subfamilies harbor a conserved QueF motif embedded in a helix flanking the active site [1,16].
The QueF motif E(S/L)K(S/A)hK(L/Y)(Y/F/W (where h is a hydrophobic residue) is characteristic
of QueF enzymes and contains residues responsible for NADPH binding. The active sites in both
subfamilies contain an invariant glutamate residue (Glu97 and Glu234 in B. subtilis QueF and V. cholerae
QueF, respectively) that anchors the preQ0 substrate in the active site, and an invariant cysteine
residue (Cys55 and Cys194 in B. subtilis QueF and V. cholerae QueF, respectively) that forms a thioimide
intermediate with preQ0 [11,12,16]. In unimodular QueF, these conserved elements are contained
within the same T-fold domain [16], whereas in bimodular QueF, the QueF motif and the active site
Cys and Glu are separated in the two domains and join together in the tertiary structure to form an
interdomain active site [12].
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Figure 3. Structural overview of the two QueF subfa ies. Crystal structures of the B. s btilis QueF
homodecamer (Protein Data Bank (PDB) ID 4F8B, [16]) as representative of the unimodular QueF
subfamily (A) and of the Vibrio Cholerae QueF homodimer (PDB ID 3S19) as representative of the
bimodular subfamily (B). Top and middle: view of the biological multimer down the central tunnel
of B. subtilis QueF and the anal gous view in V. cholerae QueF. Bottom: view of the active site at the
interface between two T-fold subunits in B. subtilis QueF and at the inter-domain interface within a
single subunit in V. cholerae QueF. Subunits are shown as ribbon diagrams in different colors. Bound
preQ0 molecules are shown in a red stick model.
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The catalytic cysteine of QueF has been shown to be prone to oxidation in vivo in the proteomes
of several Bacillus species when exposed to oxidative stress from sodium hypochlorite [20]. It has
also been shown that QueF interacts in vivo with the thioredoxin-like alkyl hydroperoxide reductase
AhpC in E. coli, suggesting that the enzyme may be regulated by the thioredoxin disulfide-thiol
exchange system [21]. Here, we present crystallographic and biochemical evidence that B. subtilis
QueF is protected from irreversible oxidation by a conserved intramolecular disulfide between the
catalytic Cys55 and a second cysteine (Cys99) located in a helix lining the active site, and that oxidative
inactivation of the enzyme is reversible with thioredoxin. Bioinformatic and phylogenetic analyses
of the two QueF subfamilies reveal a conservation pattern of the disulfide that is consistent with a
biological role in adaptation to oxidative stress environments.
2. Results and Discussion
2.1. Activity of B. subtilis QueF Mutants
Both of the Cys99 mutants exhibited robust activity (Table 1), while the Glu97Gln mutant
displayed low, but measurable, activity (~2% of wild-type). Given the significantly decreased activity
of this mutant, we carried out a full steady-state analysis to determine the kinetic constants, which
revealed a KM(preQ0) = 67 µM and kcat = 0.036/min. For comparison, the wild-type enzyme exhibits a
KM(preQ0) = 0.237 µM and kcat = 0.66/min [11]. The much larger impact on KM (280-fold) as compared
to kcat (18-fold) is consistent with the putative role of Glu97 in substrate binding [1,16].
Table 1. Relative catalytic activity of wild-type and mutant QueF enzymes.
Enzyme Relative Activity 1 (%)
Wild-type QueF 100 ± 4
Cys99Ala 80 ± 4
Cys99Ser 74 ± 3
Glu97Gln 1.9 ± 0.1
1 Relative activity reflects the average initial velocities for each enzyme (determined via ultraviolet-visible
spectrophotometry time course assays) divided by the average initial velocity for the wild-type enzyme. Standard
errors for the initial velocity measurements of specific enzymes ranged from 3% to 4.5%.
2.2. Formation of an Active-Site Disulfide in a Substrate-Free Mutant of B. subtilis QueF
The Glu97Gln mutant enzyme crystallized in the same space group (P3221) as previously
determined for the wild-type enzyme and the Cys55Ala mutant, both bound to preQ0 [16]. The
refined structure contains five subunits (A–E) in the crystallographic asymmetric unit and exhibits
good geometry and an R factor below 0.2 (Table 2). The overall structure shows a homodecamer
formed by two pentameric subunits organized in a face-to-face manner through coordination of the
C-terminal tails via divalent metal ions, similar to the preQ0-bound structures. However, the Glu97Gln
mutant structure is substantially more symmetric, and represents the substrate- and cofactor-free
form of the enzyme (here referred to as the apo form) as no difference electron density corresponding
to the substrate, cofactor or the product is seen in any of the ten active sites in the homodecamer.
Superposition of the Glu97Gln mutant structure with any of the preQ0-bound structures (wild-type
or Cys55Ala) reveals significant tightening of the homodecamer in the apo form relative to the
preQ0-bound form (Figure 4). Successive counterclockwise shifts in the positions of the subunits
manifests as a net rotation of subunit E by 25◦ around the tunnel five-fold axis and translation of its
center of mass along the axis by 17 Å relative to its position in the preQ0-bound structures. The most
striking difference is the formation of a disulfide bridge in all the active sites between the catalytic
Cys55 and Cys99 located in the N-terminal turn of the second helix of the tunnel fold, the helix
lining the inter-subunit interface (Figure 5). Disulfide formation is accompanied by full unwinding
of the N-terminal turn of the helix, indicating conformational flexibility of the active sites. These
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disulfides are apparently very stable, given that reducing agents were included in the purification and
crystallization buffers.
Table 2. X-ray data collection parameters and structure refinement statistics.
Data Collection: Value
Space group P3221
Unit cell (Å) 87.31, 87.31, 196.73
Wavelength (Å) 1.12709
Resolution range (Å) 50–2.5 (2.54–2.50) 1
Completeness (%) 98.0 (92.5)
Redundancy 5.0 (3.0)









R-cryst 3/R-free 4 (%) 0.189/0.257 (0.303/0.409)
Rmsd bond lengths (Å) 0.019
Rmsd bond angles (◦) 2.007








1 Highest-resolution shell information in parentheses; 2 Rmerge = Σ|Iobs − <I>|/ΣIobs, Rpim = (Σh [1/(nh − 1)]1/2
Σi | <I(h)> − I(h)i |)/Σh Σi I(h)I; 3 Crystallographic R-factor = Σ||Fobs| − |Fcalc||/Σ|Fobs|; 4 The free R-factor
was monitored with 5% of the data excluded from refinement; 5 The ten outlier residues are three glycine residues,





































three glycine  residues,  five metal binding  aspartate  residues,  and  two N‐terminal  residues. PEG: 
polyethylene glycol. 
 
Figure 4. Superposition of the crystal structures of the substrate-free Glu97Gln mutant of B. subtilis
QueF (colors) with the substrate-bound wild-type enzyme as a thioimide intermediate (grey) generated
by optimizing alignment of subunits A from both structures. Successive shifts in the positions of
subunits B–E result in tightening of the decamer in a counterclockwise screw fashion indicated by the
arrow. For clarity, only one pentamer is shown. Bound preQ0 molecules in the wild-type structure are
shown in red.
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substrate‐bound QueF structures. To confirm  this  interpretation, we generated  the Cys99Ala and 
Cys99Ser mutants of  the  enzyme  and  tested  the  effect of  the mutation on  enzyme  activity. Both 
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Disulfide Bond Dihedral Angle Energy  Server  (http://services.mbi.ucla.edu/disulfide/). All  of  the 
Figure 5. View of the intramolecular disulfide bridge in the active site of the Glu97Gln mutant of
B. subtilis QueF. (A) 2Fo-Fc electron density map (2.5 Å, contour 1.2 σ), superposed on the refined
model, in the active site region; (B) superposition in the active site region of the crystal structures of
the Glu97Gln mutant (green) and the wild-type enzyme thioimide intermediate (grey, PDB ID 4F8B)
showing conformational changes associated with disulfide formation. The two interface subunits are
shown in two shades of color. Bound preQ0 in the active site of wild-type QueF and key active site
residues are shown in stick diagram and labeled.
The observe is lfi es ot see to serve a structural role since they do not occur in the
substrate- e str ct res. c fir t is inter retati , e generate the Cys99 la and
Cys99Ser mutants of the enzyme and tested the effect o the mutation on enzyme activity. Both mutan s
were fully active (Table 1), indicating that the proteins were structurally intact and that Cys99 does not
play a catalytic ro e.
Furthermore, the structural changes s en in the ac ive sites in association with disulfide formation
suggest that the disulfides may serve a regulatory function as allosteric disulfides [22]. Disulfide
bonds in pr teins have been functionally classified based on the geometry and dihedral strain of
the bond as defined by the sign and magnitude, respectiv ly, of the five dihedral angles, χ1, χ2, χ3,
χ2
′, χ1′, which make up the bond [22,23]. In the present struct re, the χ1 and χ1′ dihedral angles
are defined by the atom groups N-Cα-Cβ-Sγ and N′-Cα′- ′-S ′, respectively, and
primed atoms belong to the Cys5 and Cys9 halves of the disulfide bond, respectively. χ2 and χ2′ are
the dihe ral a les fi - -Sγ-Sγ′ and Cα′-Cβ′-Sγ′-Sγ, respectively, and χ3 is efined by
Cβ-Sγ-Sγ′-Cβ′. W analyzed the disulfid bond geometries in the QueF Glu97Gln mutant structure
us ng the Disulfide Bond Dihedral A gle En gy Server (http://services.mbi.ucla.edu/ isulfide/). All
of the disulfides in the protein decamer exhibit dihedral angles with the signs −,−,−,+,− for χ1, χ2, χ3,
χ2
′, χ1′, respectively (Table 3), indicating a minus left-handed hook (–LHHook) geometry characteristic
of regulatory disulfides [24]. These angles and the calculated disulfide strain energy of ~13–19 kJ/mol
Biomolecules 2017, 7, 30 7 of 13
suggest an allosteric regulatory function, rather than a catalytic or structural function, for the active
site disulfides of QueF [22].
Table 3. Dihedral angles, bond lengths, and strain energies of the Cys55-Cys99 disulfides in the crystal
structure of B. subtilis Glu97Gln QueF mutant.
Subunit χ1 (◦) χ2 (◦) χ3 (◦)
Bond Length
(Å) χ2
′ (◦) χ1′ (◦)
Disulfide Strain
Energy (kJ/mol)
A −59.85 −126.76 −105.12 2.03 176.01 −66.90 15.023
B −56.90 −123.68 −89.05 2.03 171.20 −81.83 16.120
C −59.70 −116.71 −102.91 2.05 168.10 −63.57 14.772
D −60.93 −127.32 −79.75 2.07 173.65 −89.46 18.584
E −55.16 −120.73 −94.72 2.04 172.66 −72.34 13.938
2.3. Conservation of Disulfide-Forming Cysteines in QueF Proteins
Multisequence alignment of 2074 unimodular and 1375 bimodular QueF non-redundant sequences
from the National Center for Biotechnology Information (NCBI) database revealed that Cys99 (B. subtilis
residue numbers) is conserved in ~61% of the unimodular sequences (Table 4). An additional 22%
of the sequences lack Cys99 but harbor an alternative cysteine at position 53 (in B. subtilis residue
numbers), located in the active site loop in spatial proximity to Cys55 (based on 3D homology models,
Supplementary Figure S1), bringing the total conservation of a potential disulfide forming backdoor
cysteine to ~83%. In contrast, in bimodular QueF, the cysteine residue in a homologous position
to Cys99 is Cys236 (in V. cholerae residue numbers), and is conserved in 100% of the bimodular
sequences. Utilizing all sequences, a phylogenetic tree was generated using a multisequence alignment
of unimodular QueF with the separated N- and C-terminal modules of bimodular QueF (Figure 6).
The tree was rooted to the QueF sequence from the ancient bacteria Aquifex aeolicus. The phylogenetic
distribution indicates that unimodular QueF lacking Cys99 is the oldest variant. Gain of Cys99
occurred later in evolution but before the gene duplication event leading to bimodular QueF. Through
divergent evolution, the catalytic cysteine and Cys236 were retained in the C-terminal module of
bimodular QueF, and were lost from the N-terminal module.
Table 4. Conservation of Cys99 in unimodular QueF and the homologous residue Cys236 in bimodular
QueF. NA: Not applicable.
Unimodular QueF Bimodular QueF
Total sequences 2074 1375
% with disulfide forming cysteine (Cys99 in
unimodular QueF, Cys236 in bimodular QueF) 61% 100%
% with any potentially disulfide forming cysteine
(Cys99 or Cys53 in unimodular QueF) 83% NA
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2.4. Disulfide-Mediated Protection of QueF from Irreversible Oxidation In Vitro
Regulatory/allosteric active site disulfides in enzymes are posttranslational thiol modifications
that regulate enzyme function in a nonenzymatic way by triggering changes in the intra- or
intermolecular structure of the protein in response to a signal such as oxidative stress [22]. A common
cellular mechanism for disulfide-mediated redox sensing and response is the thioredoxin disulfide-thiol
exchange system [25]. QueF has been found to interact with the thioredoxin-like alkyl hydroperoxide
reductase protein C (AhpC) in vivo [21], prompting us to hypothesize that QueF may be a substrate
of thioredoxin and that the disulfide protects the enzyme from irreversible oxidation. To test this
hypothesis, we investigated the potential of thioredoxin to restore the activities of wild-type B. subtilis
QueF and of the mutants Cys99Ala/Ser after inactivation with hydrogen peroxide.
Thus, in vitro peroxide assays were conducted using the wild-type B. subtilis QueF and mutants
Cys99Ala/Ser. Both wild-type QueF and the Cys99Ala/Ser mutants were inactivated rapidly with
H2O2 (Figure 7A) presumably due to oxidation of the catalytic Cys55. However, the H2O2 induced
inactivation of the wild-type enzyme was reversible with thioredoxin (Figure 7B), while inactivation of
the Cys99Ala/Ser mutants was irreversible, consistent with the hypothesis that Cys55 is protected
from irreversible oxidation by disulfide formation with Cys99 in the wild-type enzyme.
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It has been demonstrated that the catalytic Cys55 of QueF is prone to oxidation in vivo
in bacilli exposed to sodium hypochlorite [20] and can be protected from overoxidation by
S-bacillithiolation, a posttranslational thiol modification constituting a biological redox control
mechanism in which protein thiols form mixed disulfides with bacillithiol, an α-anomeric glycoside of
L-cysteinyl-D-glucosamine with L-malic acid and a major low-molecular-weight thiol redox buffer in
Bacillus species and other Gram-positive bacteria. Our results suggest that thioredoxin-responsive
active site disulfides may constitute a second and more widely spread biological mechanism for
protection of QueF from irreversible oxidation in vivo. Consistent with this proposal, we observe a
higher conservation of the disulfide forming cysteine in QueF proteins from pathogenic bacteria where
oxidative stress imposed by the host immune response is high. For example, upon inspecting QueF
sequences from 164 human and plant bacterial pathogens, only seven sequences lack Cys99/Cys236,
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and six of them harbor the potential alternative Cys53 (Supplementary Table S1). Conversely, when
considering a sample of 333 QueF sequences that lack Cys99 and any alternative backdoor cysteine,
all but five are from non-pathogens. Lastly, the strict conservation of Cys236 in bimodular QueF is
consistent with the prevalence of the bimodular QueF subfamily in pathogenic bacteria (Supplementary
Table S1).
3. Materials and Methods
3.1. Mutagenesis of QueF
Mutagenesis was carried out with the QuikChange XL (Stratagene, La Jolla, CA, USA) or
QuikChange II (Agilent, Santa Clara, CA, USA) kits. The sequences of the primers used for the













The queF gene in the pET-30Xa vector [1] was used as a template to generate the single mutants.
The PCR protocol consisted of an initial hold at 94 ◦C for 45 s, followed by 18 cycles of 94 ◦C for 45 s,
55 ◦C for 60 s, and 68 ◦C for 8 min. After 18 cycles, the reaction mixtures were kept at 4 ◦C. Dpn1 (1 µL,
10 U/µL, Fermentas) was added and the reaction mixture was incubated at 37 ◦C for 1 h before the
plasmid was transformed into ultracompetent E. coli (DH5α) cells. Single colonies grown overnight
on kanamycin containing (30 µg·mL−1) agar plates were selected and cultured in 3 mL Luria-Bertani
media containing 30 µg·mL−1 for 7 h. The plasmid DNA was purified using the Qiagen miniprep kit
(Qiagen, Germantown, MD, USA), and the mutated genes sequenced to verify the mutation and the
otherwise unaltered DNA sequence. For protein expression, the mutant plasmids were transformed
into the E. coli BL21(DE3) cell line. The expression and purification of the QueF mutant proteins were
carried out as previously described for the wild-type protein [11,26].
3.2. Activity Assays of Glu97Gln and Cys99Ala/Ser Mutants
Standard assays for measuring the enzymatic activity of wild-type and mutant QueF enzymes
followed the oxidation of NADPH by ultraviolet-visible spectrophotometry (UV-Vis) as described
previously [11]. For determining the kinetic parameters of the Glu97Gln mutant, the fluorescence
assay based on the decomposition of product NADP+ was employed as previously described [11].
3.3. Crystallization, X-ray Data Collection and Crystal Structure Determination
The Glu97Gln QueF mutant was crystallized in the absence of preQ0 using the vapor diffusion
method at 293.15 K. Briefly, a sample containing 4 mg/mL protein, in 50 mM Tris pH 7.5, 50 mM KCl,
1 mM MgCl2 and 1 mM β-mercaptoethanol (BME) was prepared. Hanging drops were setup by mixing
equal volumes of sample and reservoir solution containing 19% polyethylene glycol monomethyl
ether 550, 43 mM imidazole-Cl (pH 6.8), 53 mM imidazole (pH 8.2), 30 mM CaCl2, and 4% dimethyl
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sulfoxide. Rhomb shaped crystals appeared in two days and were harvested and flash frozen in liquid
nitrogen without use of additional cryoprotectant. The X-ray data were collected using synchrotron
radiation at the Stanford Synchrotron Radiation Lightsource, beamlines 7-1. The data were processed
using HKL2000 [27]. The structure was determined using the molecular replacement Bayesian protocol
in the Phaser crystallographic software (version 2.7.17) [28] and using the structure of a single B. subtilis
QueF monomer (from PDB ID 4FGC) as a search model. The presence of the disulfide in the structure
was confirmed by difference Fourier methods using model phases with Cys55 and Cys99 deleted
from the model (omit map). The structure was refined using Refmac (version 5.8.0135) [29] and Coot
(version 0.8.2) [30]. The X-ray data and 3D coordinates have been deposited in the PDB under accession
ID 5UDG.
3.4. Sequence Analysis
A BLASTp search of the NCBI protein database, conducted using the sequence of B. subtilis
QueF, yielded a non-redundant set of ~3500 sequences. The sequences were aligned using the
Multiple Alignment Using Fast Fourier Transform (MAFFT) program within the Jalview software [31].
Sequences were checked for the simultaneous presence of the active site residues defining the QueF
family. These features include Cys55/194 (B. subtilis residue numbers/V. cholerae residue numbers),
Asp62/201, Glu97/234, and the QueF motif including Glu78/94 [1,16]. Sequences lacking any of
these features were considered non-QueF and were excluded from the analysis. The sequences
were divided into the two subfamilies, unimodular (<200 residues with a single T-fold domain) and
bimodular (>200 residues with tandem T-folds) and further examined for the presence of Cys99/236.
For sequences lacking Cys99/236, 3D homology models were produced using Phyre2 (version 2.0) [32]
and inspected for the presence of alternative cysteine residues in the active site region. Phylogenetic
analysis was conducted in the program TOPALi (version 2.5) [33] and the phylogenetic tree was
calculated using MrBayes (version 3.2) [34].
3.5. H2O2 Oxidation of Wild-Type QueF and Cys99Ala/Ser Mutants
A 120 µL stock QueF solution containing 100 mM phosphate (pH 6.5), 50 mM KCl, 20 mM
MgCl2, and 36 µM protein was prepared, and a 20 µL aliquot was removed. To the remaining stock
solution was added 5 µL of a solution of 1 mM hydrogen peroxide and this was allowed to react.
At time-points throughout the reaction (15, 30, 45, 60 or 75 s), a 20 µL aliquot was removed from the
reaction and added to a solution (80 µL) containing 12 units of catalase, and 1 mM dithiothreitoland
mixed thoroughly to quickly quench the unreacted hydrogen peroxide. The quenched solution was
then transferred to a microcuvette and preQ0 and NADPH were added to a final concentration of
100 µM and 180 µM, respectively, and the absorbance of the reaction at 340 nm was monitored over a
period of 20 min.
3.6. Activity Recovery of Oxidized QueF Enzymes
Wild type and Cys99Ala/Ser mutant enzymes of QueF were oxidized with H2O2 for 45 s under
the conditions described above. The oxidation reactions were then quenched with a solution containing
12 units of catalase and 5 equivalents of thioredoxin. At time-points throughout the reaction (10, 20,
and 30 min), a 20 µL aliquot of the solution was transferred to a microcuvette containing 100 µM preQ0
and 180 µM NADPH. The absorbance at 340 nm was monitored over a period of 20 min to determine
the initial velocity. To ensure accurate measurement of recovered activity, a control experiment was
performed in which the activity of each enzyme was measured after oxidation as described above to
ensure that each had been rendered inactive prior to treatment with thioredoxin.
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4. Conclusions
QueF is protected from irreversible oxidation by a conserved intramolecular disulfide that can
be reduced by thioredoxin, and regulation by the thioredoxin disulfide-thiol exchange system may
constitute a general mechanism for protection of QueF from oxidative stress in vivo.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-273X/7/1/30/s1.
Figure S1: 3D homology model of unimodular QueF, which lacks the disulfide forming Cys99, but contains Cys53
in proximity to the catalytic Cys55 in the active site loop. The model was generated using the Aquifex aeolicus
QueF sequence and the Phyer2 server (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index). Table S1:
Classification of 164 bacterial pathogens based on the subfamily that their QueF proteins belong to and the
presence/absence of the disulfide forming Cys99 (and the homologous Cys236 in bimodular QueF) in the
protein sequence.
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